JAK Inhibitors Have Dupixent In Their Sights For Atopic Dermatitis

 
• By Kevin Grogan
  
Itch
The atopic dermatitis market is set to be a lucrative one • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category